| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 319.91 | -29 |
| Intrinsic value (DCF) | 1685.33 | 274 |
| Graham-Dodd Method | 71.15 | -84 |
| Graham Formula | 426.33 | -6 |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.